Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05849532 · ClinicalTrials.gov registry record · NA

Home-based FES Training in People With Chronic Stroke

A NA study of Chronic Stroke, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05849532: Recruiting NA study of Chronic Stroke, sponsored by University of Illinois at Chicago.

NCT05849532 is a NA study of Chronic Stroke that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 30 participants, below the 42-participant average among 20 other Chronic Stroke trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05849532, a NA study of Chronic Stroke, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke. 30 individuals with chronic stroke will first undergo initial screening and baseline walking, mobility, balance and strength assessments in the laboratory. After determining their eligibility for the study, they will undergo 12-weeks of home-based FES and task-specific training. Following the initial screening (week 1) and pre-intervention assessment (week 2), participants will be trained in the lab for 6 sessions (week 3-4) for a FES home program and then given a FES home kit (FES device and an android tablet). Participants will then undergo home-training for 2 weeks (week 5-6) followed by mid-training assessment (week 7). Again, participants will undergo 4-weeks of home training (week 8-11) and final assessment at the end of training (week 12). This project has the following specific aims: Aim 1: To investigate the feasibility, safety and efficacy of 12-weeks of home-based FES and task-specific training in adults with chronic stroke. Aim 2: To examine the effect of 12-weeks of home-based FES and task-specific training on mobility, gait and balance (anticipatory and reactive balance) in adults with chronic stroke.

Primary Outcome

Berg Balance Scale is a 14-point scale that is widely used in the clinic and research settings to test dynamic balance in different populations. This outcome measure tests the balance during various daily living activities including sit to stand, transferring from bed to chair, reaching forward with an outstretched arm, placing alternating foot on stool amongst others. Out of a total score of 56, a score of less than 40 is considered to at moderate fall-risk in people with chronic stroke. A scor

Conditions Studied

Interventions

  • DEVICE Functional Electrical Stimulation

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-12-10
Est. Completion 2026-03-30
Phase NA
University of Illinois at Chicago

430 total trials

What NCT05849532 shows while recruiting

NCT05849532 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 42-participant average among 20 other Chronic Stroke trials with a reported enrollment target (29% lower).

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Functional Electrical Stimulation is the first listed.

NCT05849532 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05849532 about?

NCT05849532 is a clinical study titled "Home-based FES Training in People With Chronic Stroke". This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke. 30 individuals with chronic stroke will f...

What is the current status of trial NCT05849532?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-12-10. Estimated completion is 2026-03-30.

What conditions does trial NCT05849532 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT05849532?

The interventions under investigation include: Functional Electrical Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05849532?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05849532 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05849532's enrollment target sits among peer trials

30 11th of 20 higher than 10 of 20 other Chronic Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05849532, the US trial registry maintained by the National Library of Medicine. NCT05849532 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.